Skip to content

C84.7A

Billable

Anaplastic large cell lymphoma, ALK-negative, breast

HCC Category Mapping

V28HCC 19Lymphoma and Other Cancers
0.105
V24HCC 10Lymphoma and Other Cancers
0.675
ESRDHCC 10Lymphoma and Other Cancers
0.000
RxHCCHCC 21Hodgkin Lymphoma and Other Cancers
0.000

What This Code Means

A type of aggressive lymphoma (cancer of immune cells) that starts in the breast and does not have a specific genetic marker called ALK.

Coding Tips

  • Verify the ALK-negative status is documented in the pathology report before assigning this code
  • This code is specific to breast involvement; confirm the primary site is the breast and not metastatic disease

Clinical Significance

Anaplastic large cell lymphoma, ALK-negative, involving the breast is a clinically significant code that specifically captures breast implant-associated ALCL (BIA-ALCL) and other breast-based ALCL. BIA-ALCL is a recognized entity associated with textured breast implants and typically presents as a late-onset periprosthetic seroma or mass. Early-stage BIA-ALCL confined to the capsule has excellent prognosis with implant removal, while advanced disease requires systemic therapy.

Documentation Requirements

  • Pathology confirming ALCL with CD30 positivity and ALK-negative status in breast tissue
  • Documentation of breast implant history if applicable
  • Description of presentation (seroma, mass, capsular involvement)
  • Staging of breast involvement (confined to capsule vs. beyond capsule vs. disseminated)
  • Bilateral implant status documented if relevant

Use Additional Code

  • code to identify:
  • breast implant status (Z98.82)
  • personal history of breast implant removal (Z98.86)

Commonly Confused Codes

Code Hierarchy

Open C84.7A in the Interactive Encoder

See full code details, AI coding tips, HCC mappings, and related codes in our interactive encoder. Start your 14-day Pro trial — no credit card required.